Intervention to reduce the risk of diabetic retinopathy and early adverse retinal changes in type 1 diabetes

年轻发病的T1D的长期影响可能是毁灭性的：糖尿病是澳大利亚和其他国家年轻人视力丧失的主要原因。我们有独特的机会来研究ACEI和他汀类药物是否会通过我们与已经资助的国际多中心试验的合作来改善视网膜病变。这项研究将治疗青少年4年，并将在接下来的5-10年内对他们进行跟踪调查。我们将使用新的测量视网膜血管大小和分数的方法。

The long term effects of young onset T1D may be devastating: diabetes is the leading cause of visual loss in young adults in Australia and other countries. We have the unique opportunity to investigate whether ACEI and statins will modify retinopathy through our collaboration with an already funded international multicentre trial. This study will treat adolescents for 4 years and will follow them for the next 5-10 years. We will use novel measures of retinal blood vessels size and fractals.